Results 221 to 230 of about 9,549 (243)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Böll, Victoria Metaxa   +2 more
exaly  

(16) Nodular non-Langerhans cell histiocytosis

British Journal of Dermatology, 1990
openaire   +2 more sources

[Non-Langerhans cell histiocytosis: a case report and literature review].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2013
Quande Lin, Lihua Dong, Lijuan Zhang, Xudong Wei, Yufu Li, Xue Gao, Yongping Song   +6 more
openaire   +3 more sources

Langerhans cell and non Langerhans cell histiocytosis: So different?

, 2007
The Author reports the clinical and laboratory criteria that do not support the strict distinction between Langerhans cell and non Langerhans cell histiocytosis as reported in the relevant literature.
C. Gelmetti
openalex   +2 more sources

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Marion Smits, Priscilla K Brastianos   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

The rapidly changing landscape in mature T‐cell lymphoma (MTCL) biology and management

Ca-A Cancer Journal for Clinicians, 2020
Enrica Marchi
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
exaly  

Oral cavity and oropharyngeal squamous cell carcinoma—an update

Ca-A Cancer Journal for Clinicians, 2015
Angela C Chi
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro Coelho Barata, Brian I Rini
exaly